ITMCTR2100004499招募中1 期
Yishengukang Decoction for strengthening the healthy, detoxifying and removing blood stasis in the treatment of cancerous somatic pain:A Multi-Center Randomized Controlled Trial
Qinglin Zhang0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 80（—）
- 性别
- All
入选标准
- •1) Aged 18-80 years;
- •2) Accordance with the diagnostic criteria of Western medicine for carcinomatous somatic pain;
- •3) TCM syndrome differentiation belongs to kidney deficiency and (or) stagnation of blood stasis and toxin;
- •4) NRS > 3 for moderate to severe cancer somatic pain;
- •5) KPS > 30;
- •6) The expected survival time Will be more than 3 months;
- •7) Voluntarily accept the study and sign the letter of understanding.
排除标准
- •1) Radiotherapy, chemotherapy or nerve block therapy were applied to the affected or painful part of the tumor within 1 month before the beginning of the observation period;
- •2) Non cancerous pain, as if accompanied by tumor emergency related pain, tumor related other neuropathic pain;
- •3) Have a history of drug abuse or addiction;
- •4) Allergic to the test drug;
- •5) Patients with severe organ dysfunction;
- •6) Those who can't cooperate with the treatment plan and can't evaluate their pain and general condition.
研究者
相似试验
招募中
Unknown
Yangxue Qingluo Mingmu Decoction for the Treatment of High Myopia Caused by Deficiency Fire and Collateral Damage Clinical study of macular hemorrhageMacular hemorrhage in high myopiaITMCTR2023000012Eye Hospital of China Academy of Chinese Medical Sciences
尚未招募
4 期
Yiqi Yangyin Jiedu decoction combined with chemotherapy in the treatment of advanced lung adenocarcinoma with EGFR sensitive mutation after TKI resistance: a randomized controlled double-blind studyITMCTR2000003622Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
尚未招募
不适用
Clinical study of Yigu Decoction regulating intestinal microecology in patients with osteoporotic hip fractureosteoporosisITMCTR2200005594The Third Affiliated Hospital of Zhejiang Chinese Medical University
招募中
1 期
A clinical study of Yiqi Huayu Jiedu decoction reducing the risk of postoperative gastric cancer recurrence and metastasis: Study protocol for a randomized controlled trailGastric CancerITMCTR2000003294Jiangsu Province Hospital of Chinese Medicine
尚未招募
1 期
Clinical study on Yanghe Decoction in improving neo-adjuvant chemotherapy efficacy and immune function of breast cancer patientsbreast cancerITMCTR2000003712Yueyang Hospital of Integrated Chinese and Western Medicine, Shanghai University of TCM